FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095364 [Registered on: 24/09/2025] Trial Registered Prospectively
Last Modified On: 17/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Improving Breathing, Balance, and Daily Life through Telerehabilitation in People with COPD 
Scientific Title of Study   Effect of Telerehabilitation on the Pulmonary Functions, Balance, Cognition and Functional Outcomes among individuals with COPD 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Mandeep K Jangra (PT) 
Designation  ASSOCIATE PROFESSOR 
Affiliation  MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION 
Address  Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, MM(DU), MULLANA, AMBALA

Ambala
HARYANA
133207
India 
Phone  9416797708  
Fax    
Email  mandeep.jangra@mmumullana.org  
 
Details of Contact Person
Scientific Query
 
Name  Mandeep K Jangra 
Designation  ASSOCIATE PROFESSOR 
Affiliation  MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION 
Address  Maharishi Institute of Physiotherapy and Rehabilitation, MM(DU), MULLANA, AMBALA

Ambala
HARYANA
133207
India 
Phone  9416797708  
Fax    
Email  mandeep.jangra@mmumullana.org  
 
Details of Contact Person
Public Query
 
Name  Mandeep K Jangra 
Designation  ASSOCIATE PROFESSOR 
Affiliation  MAHARISHI MARKANDESHWAR INSTITUTE OF PHYSIOTHERAPY AND REHABILITATION 
Address  Maharishi Institute of Physiotherapy and Rehabilitation, MM(DU), MULLANA, AMBALA

Ambala
HARYANA
133207
India 
Phone  9416797708  
Fax    
Email  mandeep.jangra@mmumullana.org  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Ridhi Vatsa 
Address  Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, MM(DU), Mullana, Ambala, 133207 
Type of Sponsor  Other [Physiotherapy ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ridhi Vatsa  Respiratory OPD, MMIMSR, Mullana-Ambala  MM Superspeciality Hospital, MM(DU), Mullana-Ambala
Ambala
HARYANA 
9876757689

vatsaridhi14@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J441||Chronic obstructive pulmonary disease with (acute) exacerbation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Home Based Pulmonary Rehabilitation  Patients in Control group will perform the exercises unsupervised and will maintain a log book on daily basis. After 6 weeks, they will report back for comparison of the parameters. 
Intervention  Pulmonary Telerehabilitation  Patients in Experimental group will receive supervised telerehabilitation for 6 weeks. Total duration of the session will be 40 mins. 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  Diagnosis of COPD with FEV1 more than 50%
Consent to participate
MoCA score more than 25 
 
ExclusionCriteria 
Details  Neurological Disorders
Any Cardiovascular Disorders
Any Pulmonary Conditions Other than COPD
Musculoskeletal Disorders
Diagnosis of COPD with FEV1 less than 50%
Patient’s Refusal 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
FEV1, FVC, FEV1/FVC
Functional performance and ADL
Cognition
Balance 
FEV1, FVC, FEV1/FVC
Functional performance and ADL
Cognition
Balance 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   06/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Chronic Obstructive Pulmonary Disease (COPD) is a global health concern with high incidence and mortality rates, largely resulting from airway and alveolar abnormalities that often lead to irreversible airflow limitation. More than 70% of COPD patients are diagnosed at stage 1 or stage 2, as per the GOLD criteria, and may exhibit minimal or no apparent symptoms like exercise limitation and dyspnea. However, these individuals still face significant challenges affecting their physical independence and overall health. Exercise training is a powerful intervention to improve exercise tolerance, skeletal and respiratory muscle function, movement efficiency, dyspnoea and fatigue symptoms, and health-related quality of life. The traditional methods are often ineffective for this population due to barriers such as geographic distance, limited access to healthcare facilities, and financial constraints. The primary pulmonary rehabilitation programs delivered by telerehabilitation can provide a clinically effective alternative to centre-based rehabilitation models. The purpose of this study is to evaluate the effectiveness of telerehabilitation on pulmonary outcomes, balance, cognition, and functional outcomes in individuals with mild to moderate COPD. This research aims to bridge the existing gap by providing insights into functional outcomes and the potential of telerehabilitation to improve Activities of Daily Living (ADL) performance. The findings from this research could provide valuable insights into the role of telerehabilitation in managing COPD, particularly in enhancing daily functional capacity. In this study, individuals with COPD (FEV1 > 50%) aged between 45-80 years will be invited from respiratory medicine for screening purposes. The 60 eligible candidates, as per the eligibility criteria, will be selected, and consent will be procured. Further, they will be divided into two random groups, Group 1 (Experimental Group) will receive telerehabilitation, whereas Group 2 (Control Group) will receive conventional rehabilitation. Participants will undergo a structured pre- and post-test (after 6 weeks) evaluation to assess the impact of telerehabilitation on their pulmonary outcomes, balance, cognition, and functional outcomes. At the baseline and end of the program, the pulmonary outcomes will be measured with the help of RMS Helios 401, functional outcomes using Londrina ADL protocol, cognition with MoCA, and balance using the Berg Balance Scale will be administered. Data collected will be statistically analysed to determine the effectiveness of telerehabilitation. Comparative analysis between pre-and post-test results will be conducted to evaluate improvements in functional performance, and the findings will be used to assess the intervention’s efficacy.


 
Close